Altimmune Inc
NASDAQ:ALT
Altimmune Inc?
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.67
9.85
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Altimmune Inc
What unique competitive advantages
does Altimmune Inc hold over its rivals?
What risks and challenges
does Altimmune Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Altimmune Inc.
Provide an overview of the primary business activities
of Altimmune Inc.
What unique competitive advantages
does Altimmune Inc hold over its rivals?
What risks and challenges
does Altimmune Inc face in the near future?
Has there been any significant insider trading activity
in Altimmune Inc recently?
Summarize the latest earnings call
of Altimmune Inc.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Altimmune Inc.
Provide P/S
for Altimmune Inc.
Provide P/E
for Altimmune Inc.
Provide P/OCF
for Altimmune Inc.
Provide P/FCFE
for Altimmune Inc.
Provide P/B
for Altimmune Inc.
Provide EV/S
for Altimmune Inc.
Provide EV/GP
for Altimmune Inc.
Provide EV/EBITDA
for Altimmune Inc.
Provide EV/EBIT
for Altimmune Inc.
Provide EV/OCF
for Altimmune Inc.
Provide EV/FCFF
for Altimmune Inc.
Provide EV/IC
for Altimmune Inc.
Show me price targets
for Altimmune Inc made by professional analysts.
What are the Revenue projections
for Altimmune Inc?
How accurate were the past Revenue estimates
for Altimmune Inc?
What are the Net Income projections
for Altimmune Inc?
How accurate were the past Net Income estimates
for Altimmune Inc?
What are the EPS projections
for Altimmune Inc?
How accurate were the past EPS estimates
for Altimmune Inc?
What are the EBIT projections
for Altimmune Inc?
How accurate were the past EBIT estimates
for Altimmune Inc?
Compare the revenue forecasts
for Altimmune Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Altimmune Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Altimmune Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Altimmune Inc compared to its peers.
Compare the P/E ratios
of Altimmune Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Altimmune Inc with its peers.
Analyze the financial leverage
of Altimmune Inc compared to its main competitors.
Show all profitability ratios
for Altimmune Inc.
Provide ROE
for Altimmune Inc.
Provide ROA
for Altimmune Inc.
Provide ROIC
for Altimmune Inc.
Provide ROCE
for Altimmune Inc.
Provide Gross Margin
for Altimmune Inc.
Provide Operating Margin
for Altimmune Inc.
Provide Net Margin
for Altimmune Inc.
Provide FCF Margin
for Altimmune Inc.
Show all solvency ratios
for Altimmune Inc.
Provide D/E Ratio
for Altimmune Inc.
Provide D/A Ratio
for Altimmune Inc.
Provide Interest Coverage Ratio
for Altimmune Inc.
Provide Altman Z-Score Ratio
for Altimmune Inc.
Provide Quick Ratio
for Altimmune Inc.
Provide Current Ratio
for Altimmune Inc.
Provide Cash Ratio
for Altimmune Inc.
What is the historical Revenue growth
over the last 5 years for Altimmune Inc?
What is the historical Net Income growth
over the last 5 years for Altimmune Inc?
What is the current Free Cash Flow
of Altimmune Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Altimmune Inc.
ALT's latest stock split occurred on Sep 14, 2018
The company executed a 1-for-30 stock split, meaning that for every 30 shares held, investors received 1 new share.
Before the split, ALT traded at 0.26 per share. Afterward, the share price was about 5.45.
The adjusted shares began trading on Sep 14, 2018. This was the only stock split in ALT's history.
Global
Stock Splits Monitor
| Date | Company | Split | Pre-Split Price | Post-Split Price | |
|---|---|---|---|---|---|
|
Apr 22, 2025
|
|
Seres Therapeutics Inc
SWB:1S9
|
1-for-20
/20
|
0.3216 6.432 EUR | 6.432 6.432 EUR |
|
Apr 22, 2025
|
G
|
Golden Shield Resources Inc
F:4LE0
|
1-for-10
/10
|
0.011 0.11 EUR | 0.11 0.11 EUR |
|
Apr 22, 2025
|
E
|
EV Advanced Material Co Ltd
KOSDAQ:131400
|
911-for-787
x1.1575603557814
|
1493 1493 KRW | 1439 1439 KRW |
|
Apr 22, 2025
|
|
Seres Therapeutics Inc
F:1S9
|
1-for-20
/20
|
0.01 0.2 EUR | 0.2 0.2 EUR |
|
Apr 22, 2025
|
G
|
Golden Shield Resources Inc
OTC:GSRFF
|
1-for-10
/10
|
0.024 0.24 USD | 0.24 0.24 USD |
1S9
Altimmune Inc
Glance View
Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on peptide-based therapeutics for obesity and liver diseases. The company is headquartered in Gaithersburg, Maryland and currently employs 47 full-time employees. The company went IPO on 2005-10-06. The Company’s lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and non-alcoholic steatohepatitis (NASH). The company is also developing HepTcell, an immunotherapeutic agent designed to achieve a functional cure for chronic hepatitis B. The firm has initiated a Phase II clinical trial of HepTcell and are in Phase II and Phase I clinical development with pemvidutide for multiple indications. The company is conducting its Phase II clinical trial of HepTcell in the United States, United Kingdom, Canada, Germany and Spain, and conducting Its pemvidutide Phase I clinical trial in Australia. Its wholly owned subsidiaries include Altimmune, LLC, Altimmune UK, Limited, Spitfire Pharma, LLC and Altimmune AU Pty, Limited.
You don't have any saved screeners yet